Liposomal Doxorubicin and Trastuzumab in Treating Women With Advanced Breast Cancer

NCT00006825 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: trastuzumab
DRUG: pegylated liposomal doxorubicin hydrochloride

Sponsor

NYU Langone Health

Collaborators

[object Object]